Billionaires Holding RCPT

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 27.4M
    Shares Outstanding

  • 3.542B
    Market Cap

News & Insights

ABOUT

RCPT

Receptos, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics for immune disorders. Its lead product includes RPC1063, an oral sphingosine 1-phosphate 1 receptor modulator that is in Phase II portion of Phase II/II...

Apple And Berkshire Hathaway: When Two Worlds Collide

NEWS

Icahn: Best Bet On Commodities

READ MORE